Anebulo Pharmaceuticals, Inc. (ANEB): Shares Outstanding

Annual figures by period end, from SEC filings.

41.08M
As of 2025-06-30
41.08M
As of 2025-12-31
+20.7%
3-year compound annual growth
2020-06-30: 12.00M2021-06-30: 23.34M2022-06-30: 23.34M2023-06-30: 25.63M2024-06-30: 25.93M2025-06-30: 41.08M41.08M
2020-06-30 Shares Outstanding (shares) 2025-06-30
Period endedShares OutstandingChange YoYSource filing
2025-06-3041.08M+58.4%2025-09-29, Balance as of period end
2024-06-3025.93M+1.2%2025-09-29, Balance as of period end
2023-06-3025.63M+9.8%2024-09-25, Balance as of period end
2022-06-3023.34M0.0%2023-09-22, Balance as of period end
2021-06-3023.34Mn/c2022-09-09, Balance as of period end
2020-06-3012.00Mn/a2021-09-22, Balance as of period end